(Q44903736)

7 December 2017

Lyme disease--what is the cost for Scotland? (English)

1 reference

7 December 2017

0 references

Joss AW

1

1 reference

7 December 2017

Davidson MM

series ordinal

2

1 reference

7 December 2017

Ho-Yen DO

series ordinal

3

1 reference

7 December 2017

Ludbrook A

series ordinal

4

1 reference

7 December 2017

language of work or name

1 reference

1 July 2003

1 reference

7 December 2017

1 reference

7 December 2017

117

1 reference

7 December 2017

4

1 reference

7 December 2017

264-273

1 reference

Lyme disease-a tick-borne spirochetosis?

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

The Spirochetal Etiology of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Systematic review of the treatment of early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

1 reference

7 January 2021

A cost-of-illness study of Lyme disease in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

The cost effectiveness of vaccinating against Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

An epidemiologic study of Lyme disease in southern Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Diagnosis, treatment, and prevention of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Treatment of late Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Evidence-based diagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Improved serodiagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Lyme borreliosis: basic science and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Primary Cutaneous B-Cell Lymphoma and Borrelia burgdorferi Infection in Patients From the Highlands of Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

The Overdiagnosis of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Chronic neurologic manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Long-term Outcomes of Persons With Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Doxycycline for tick bites--not for everyone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Prevention of Lyme disease after tick bites. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Death from inappropriate therapy for Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2803%2900067-2

7 January 2021

10.1016/S0033-3506(03)00067-2

Identifiers

DOI

1 reference

7 December 2017

1 reference